References
1. Wei WI, Sham JST. Nasopharyngeal carcinoma. In: Lancet . ; 2005.
2. Baujat B, Audry H, Bourhis J, et al. Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma.Cochrane Database Syst Rev . Published online 2009.
3. Ondrey FG, Greig JR, Herscher L. Radiation dose to otologic structures during head and neck cancer radiation therapy.Laryngoscope . Published online 2000.
4. Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys . Published online 2005.
5. Shah N. Otitis media and its sequelae. J R Soc Med . Published online 1991.
6. Rosenfeld RM, Kay D. Natural history of untreated otitis media.Laryngoscope . Published online 2003.
7. Hunt MA, Zelefsky MJ, Wolden S, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys . Published online 2001.
8. Teo PML, Ma BBY, Chan ATC. Radiotherapy for nasopharyngeal carcinoma - Transition from two-dimensional to three-dimensional methods.Radiother Oncol . Published online 2004.
9. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys . Published online 2002.
10. McMillan AS, Pow EHN, Kwong DLW, et al. Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: Results of a prospective longitudinal study.Head Neck . Published online 2006.
11. Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet (London, England) . 2019;394(10192):64-80.
12. Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys . 2007;67(2):469-479.
13. Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. Radiotherapy-induced ear toxicity. Cancer Treat Rev . 2003;29(5):417-430.
14. Lambert EM, Gunn GB, Gidley PW. Effects of radiation on the temporal bone in patients with head and neck cancer. Head Neck . 2016;38(9):1428-1435.
15. Kew J, King AD, Leung SF, et al. Middle ear effusions after radiotherapy: correlation with pre-radiotherapy nasopharyngeal tumor patterns. Am J Otol . 2000;21(6):782-785.
16. Liang K-L, Hsin C, Chen T, Liang K. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy. Laryngoscope . 2013;123(9):2148-2153.
17. Liang K-L, Su M-C, Twu C-W, Jiang R-S, Lin J-C, Shiao J-Y. Long-term result of management of otitis media with effusion in patients with post-irradiated nasopharyngeal carcinoma. Eur Arch oto-rhino-laryngology Off J Eur Fed Oto-Rhino-Laryngological Soc Affil with Ger Soc Oto-Rhino-Laryngology - Head Neck Surg . 2011;268(2):213-217.
18. Hsin C-H, Chen T-H, Young Y-H, Liu W-S. Comparison of otologic complications between intensity-modulated and two-dimensional radiotherapies in nasopharyngeal carcinoma patients. Otolaryngol neck Surg Off J Am Acad Otolaryngol Neck Surg . 2010;143(5):662-668.
19. Zhao L, Chen H, Hu B, Zhang H, Lin Q. Prognostic significance of Ki67 expression and the derived neutrophil-lymphocyte ratio in nasopharyngeal carcinoma. Cancer Manag Res . 2018;10:1919-1926.
20. Young YH, Lin KL, Ko JY. Otitis media with effusion in patients with nasopharyngeal carcinoma, postirradiation. Arch Otolaryngol Head Neck Surg . 1995;121(7):765-768.
21. Ohashi Y, Nakai Y, Esaki Y, Ikeoka H, Koshimo H, Onoyama Y. Acute effects of irradiation on middle ear mucosa. Ann Otol Rhinol Laryngol . 1988;97(2 Pt 1):173-178.
22. BERG NO, LINDGREN M. Dose factors and morphology of delayed radiation lesions of the internal and middle ear in rabbits. Acta radiol . 1961;56:305-319.
Table 1 – Demographic and clinical data